“…To our knowledge, there are no available data on NA recognition of ␣2,9-linked sialic acids, which are typical of serogroup C capsules. However, molecular modeling studies showed that the active site of influenza virus N9 NA has enough space to accommodate substrates bearing the four types of glycosidic linkages (39). Whatever the serogroup, the exosialidase activity of the viral NA is unlikely to lead to a complete disruption of the capsule.…”